SOX18通过上调KLF4促进血管瘤内皮细胞增殖并抑制其凋亡

doi:10.3969/j.issn.1005-4979.2019.05.002

摘要/Abstract

摘要： 目的：构建表达SOX18的真核表达载体，并合成靶向于SOX18的siRNA，探索SOX18调控血管瘤内皮细胞（hemangioma-derived endothelial cell, HemECs）增殖的机制。方法：检测SOX18及相关基因在临床样本中的表达。构建SOX18的真核表达载体，通过转染该真核表达载体以及靶向于SOX18的siRNA，实现过表达和敲减SOX18。以细胞计数的方法检测SOX18对血管内皮细胞增殖的影响；流式细胞术检测超表达和敲减SOX18后对细胞凋亡的影响；qRT-PCR检测过表达和敲减SOX18后对相关基因的调控作用。结果：SOX18在血管瘤组织总的表达显著高于正常组织。成功构建了过表达SOX18的真核表达载体pCMV-HA-SOX18，并验证其能够在HemECs细胞内过表达。此外，结合siRNA敲减实验，证实SOX18能够促进HemECs增殖并抑制其凋亡。qRT-PCR检测和Western Blot检测证明SOX18能够上调KLF4和VEGF-C的表达。结论：SOX18能够通过促进KLF4和VEGF-C的表达促进HemECs增殖。

关键词: SOX18, 血管瘤, 细胞增殖, 凋亡

Abstract: Objective: To construct the recombinant plasmid containing SOX18 gene and investigate the effect of the protein on vascular endothelial cells from the source of hemangiomas. To explore the mechanism of SOX18 in regulating the proliferation of vascular endothelial cells. Methods: qRT-PCR was used to detect the SOX18 expression levels in hemangiomas tissues and adjacent tissues. The SOX18-overexpressing recombinant plasmid pCMV-HA-SOX18 or specific siRNA targeting SOX18 were transfected into vascular endothelial cells. Cell counting assay was performed to evaluate the cell proliferation. The cell apoptosis was detected by flow cytometry method. qRT-PCR was used to determine the expression of the cell proliferation related genes. Results: The SOX18 expression was significantly increased in hemangiomas tissues. Overexpression of SOX18 promoted cell proliferation and inhibited apoptosis in vascular endothelial cell. qRT-PCR and Western blot results suggest that SOX18 could increase the expressions of KLF4 and VEGF-C. Conclusion: SOX18 could promote KLF4 and VEGF-C expression to affect cell proliferation.

Key words: SOX18, hemangioma, cell proliferation, apoptosis

中图分类号:

R782

伦瑞花，李小亮. SOX18通过上调KLF4促进血管瘤内皮细胞增殖并抑制其凋亡[J]. 《口腔颌面外科杂志》, doi: 10.3969/j.issn.1005-4979.2019.05.002.

LUN Rui-hua, LI Xiao-liang. SOX18 Promotes Endothelial Cells of Hemangioma Proliferation and Suppresses Apoptosis Through Targeting KLF4[J]. 《Journal of Oral and Maxillofacial Surgery》, doi: 10.3969/j.issn.1005-4979.2019.05.002.

https://journal06.magtech.org.cn/Jweb_joms/CN/Y2019/V29/I5/245

参考文献

[1] 郑家伟,周琴,王延安,等.口腔颌面部血管瘤治疗指南[J].中国口腔颌面外科杂志, 2011, 9(1):61-67. [2] 唐东方,尤金良,李伟,等.新生儿幼年性巨大毛细血管瘤1例报告[J].中风与神经疾病杂志,2018,35(1):81-82. [3] Francois M, Harvey NL, Hogan BM. The transcriptional control of lymphatic vascular development[J]. Physiology (Bethesda)，2011，26(3):146-155. [4] 钱世宁,朱小飞,季明德,等.含人SOX18基因真核表达载体的构建及其重组蛋白诱导血管内皮细胞增殖的研究[J].南京医科大学学报(自然科学版),2018,38(2):166-170. [5] Wang G, Wei Z, Jia H, et al. Knockdown of SOX18 inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells[J]. Oncol Rep, 2015，34(3):1121-1128. [6] Yang N, Wang Y, Hui L, et al. SOX 1, contrary to SOX 2, suppresses proliferation, migration, and invasion in human laryngeal squamous cell carcinoma by inhibiting the Wnt/β-catenin pathway[J]. Tumour Biol, 2015,36(11):8625-8635. [7] Xu YR, Yang WX. SOX-mediated molecular crosstalk during the progression of tumorigenesis[J]. Semin Cell Dev Biol,2017,63:23-34. [8] Fran?觭ois M, Caprini A, Hosking B, et al. Sox18 induces development of the lymphatic vasculature in mice[J]. Nature, 2008,456(7222):643-647. [9] 马丽莉. SOX18，血管内皮生长因子C（VEGF-C）和血管内皮生长因子受体3（VEGFR-3）在胃癌中的表达及意义[D]. 长沙: 中南大学,2012. [10] Young N, Hahn CN, Poh A, et al. Effect of disrupted SOX18 transcription factor function on tumor growth, vascularization, and endothelial development[J]. J Natl Cancer Inst, 2006,98(15):1060-1067. [11] Duong T, Proulx ST, Luciani P, et al. Genetic ablation of SOX18 function suppresses tumor lymphangiogenesis and metastasis of melanoma in mice[J] Cancer Res, 2012,72(12):3105-3114. [12] Huaqi Y, Caipeng Q, Qiang W, et al. The role of SOX18 in bladder cancer and its underlying mechanism in mediating cellular functions[J]. Life Sci, 2019, 232:116614. [13] Miao Z, Deng X, Shuai P, et al.Upregulation of SOX18 in colorectal cancer cells promotes proliferation and correlates with colorectal cancer risk[J]. Onco Targets Ther, 2018,11:8481-8490. [14] Matsui T, Kanai-Azuma M, Hara K, et al. Redundant roles of Sox17 and Sox18 in postnatal angiogenesis in mice[J]. J Cell Sci, 2006, 119(Pt 17):3513-3526. [15] Cermenati S, Moleri S, Cimbro S, et al. Sox18 and Sox7 play redundant roles in vascular development[J]. Blood, 2008, 111(5):2657-2666. [16] Herpers R, van de Kamp E, Duckers HJ, et al. Redundant roles for sox7 and sox18 in arteriovenous specification in zebrafish[J]. Circ Res, 2008, 102(1):12-15. [17] Zhu W, Wang Y, Zhang D, et al. MiR-7-5p functions as a tumor suppressor by targeting SOX18 in pancreatic ductal adenocarcinoma[J]. Biochem Biophys Res Commun, 2018, 497(4):963-970. [18] Petrovic I, Kovacevic-Grujicic N, Stevanovic M. Early growth response protein 1 acts as an activator of SOX18 promoter[J]. Exp Mol Med, 2010, 42(2):132-142. [19] Yin H, Sheng Z, Zhang X, et al. Overexpression of SOX18 promotes prostate cancer progression via the regulation of TCF1, c-Myc, cyclin D1 and MMP-7[J]. Oncol Rep, 2017, 37(2):1045-1051. [20] Xu Y, Zhang Q, Zhou J, et al. Down-regulation of SOX18 inhibits laryngeal carcinoma cell proliferation, migration, and invasion through JAK2/STAT3 signaling[J]. Biosci Rep,2019, 39(7) . [21] Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele[J]. Nature, 1996, 380(6573):435-439. [22] Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene[J]. Nature, 1996, 380(6573):439-442. [23] Liang S, Yu H, Chen X, et al. PDGF-BB/KLF4/VEGF Signaling Axis in Pulmonary Artery Endothelial Cell Angiogenesis[J]. Cell Physiol Biochem, 2017,41(6):2333-2349. [24] Choi D, Park E, Jung E, et al. ORAI1 Activates Proliferation of Lymphatic Endothelial Cells in Response to Laminar Flow Through Krüppel-Like Factors 2 and 4[J]. Circ Res, 2017, 120(9):1426-1439.

选择文件类型/文献管理软件名称

选择包含的内容